![]() |
Volumn 16, Issue 12, 2007, Pages 1867-1878
|
Discontinued drugs in 2006: Anti-infectives
|
Author keywords
Anti infectives; Coronavirus; Discontinued drugs; HIV; Pseudomonas aeruginosa; Respiratory syncytial virus; SARS virus; Severe acute respiratory syndrome
|
Indexed keywords
4' AZIDOCYTIDINE;
A 33903;
A 60444;
AERUGEN;
ALPHA GLYCINAMIDE;
ANGIOTENSIN 2 RECEPTOR ANTAGONIST;
ANTIINFECTIVE AGENT;
BENZODIAZEPINE DERIVATIVE;
BISMUTH 201;
BMS 2;
BMS 605339;
DIDANOSINE;
DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;
ELVUCITABINE;
GR 270773;
HEPATITIS C VIRUS PROTEASE INHIBITOR;
MONOCLONAL ANTIBODY;
PLACEBO;
PROTEIN INHIBITOR;
PROTEINASE INHIBITOR;
PSEUDOMONAS VACCINE;
RIBAVIRIN;
SEVERE ACUTE RESPIRATORY SYNDROME VACCINE;
SINOVAC;
UNCLASSIFIED DRUG;
ABSENCE OF SIDE EFFECTS;
ACQUIRED IMMUNE DEFICIENCY SYNDROME;
ADD ON THERAPY;
ANTIVIRAL ACTIVITY;
ARTICLE;
CARDIOVASCULAR DISEASE;
CHEMICAL STRUCTURE;
CLINICAL TRIAL;
CONTINUOUS INFUSION;
CYSTIC FIBROSIS;
DENGUE;
DRUG ABSORPTION;
DRUG BIOAVAILABILITY;
DRUG MEGADOSE;
DRUG SAFETY;
DRUG TOLERABILITY;
DRUG WITHDRAWAL;
HEPATITIS C VIRUS;
HIGHLY ACTIVE ANTIRETROVIRAL THERAPY;
HUMAN;
HUMAN IMMUNODEFICIENCY VIRUS;
HUMAN IMMUNODEFICIENCY VIRUS INFECTION;
HYPERLIPIDEMIA;
IMMUNE RESPONSE;
IMMUNOSTIMULATION;
MONOTHERAPY;
NEOPLASM;
NONHUMAN;
PROTEIN SYNTHESIS;
SEPSIS;
SEPTIC SHOCK;
SEVERE ACUTE RESPIRATORY SYNDROME;
SINGLE DRUG DOSE;
TREATMENT INDICATION;
TREATMENT WITHDRAWAL;
UNSPECIFIED SIDE EFFECT;
VIRUS ENCEPHALITIS;
VIRUS HEMORRHAGIC FEVER;
VIRUS INFECTION;
VIRUS LOAD;
VIRUS REPLICATION;
ANIMAL;
BLOOD;
CHEMISTRY;
COMMUNICABLE DISEASE;
PHARMACEUTICS;
REVIEW;
ANIMALS;
ANTI-INFECTIVE AGENTS;
COMMUNICABLE DISEASES;
HUMANS;
TECHNOLOGY, PHARMACEUTICAL;
|
EID: 39549111525
PISSN: 13543784
EISSN: None
Source Type: Journal
DOI: 10.1517/13543784.16.12.1867 Document Type: Article |
Times cited : (2)
|
References (6)
|